Dapagliflozin
NDC 27241-152, Dapagliflozin, tablet, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-152
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211482
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-152 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-152-01 | 27241015201 | 30 TABLET in 1 BOTTLE (27241-152-01) |
| 27241-152-90 | 27241015290 | 90 TABLET in 1 BOTTLE (27241-152-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f615d81e-d1e8-4561-a4d9-286c615d3bd2NADAC price for package 27241015201
GET /v1/drugs/nadac/27241015201
Use it
Look up 27241-152 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-152 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-152. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.